sinc
outbreak
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
first
report
wuhan
seri
confirm
case
found
qinghaitibet
plateau
aim
describ
epidemiolog
clinic
characterist
outcom
confirm
case
qinghai
provinc
high
altitud
effici
measur
stop
spread
coronaviru
new
case
found
qinghai
provinc
consecut
day
feb
april
patient
confirm
infect
patient
compris
transmiss
cluster
identifi
three
patient
infect
direct
contact
without
travel
histori
wuhan
seven
patient
asymptomat
admiss
patient
patient
show
bilater
pneumonia
patient
show
abnorm
three
patient
comorbid
hypertens
liver
diseas
diabet
develop
sever
ill
high
creactiv
protein
level
elev
alt
ast
observ
sever
ill
patient
admiss
patient
eventu
discharg
includ
sever
patient
recov
treatment
noninvas
mechan
ventil
convalesc
plasma
therapi
find
confirm
humantohuman
transmiss
cluster
strategi
earli
diagnosi
earli
isol
earli
treatment
import
prevent
spread
improv
cure
rate
patient
comorbid
like
develop
sever
ill
could
benefit
convalesc
plasma
transfus
coronaviru
diseas
caus
infect
novel
sever
acut
respiratori
syndrom
coronaviru
emerg
wuhan
hubei
china
decemb
rapidli
spread
worldwid
outbreak
spread
countri
global
number
report
case
surpass
april
evid
spread
humantohuman
transmiss
increas
number
case
widen
geograph
spread
diseas
rais
global
health
concern
far
sever
studi
describ
epidemiolog
clinic
featur
data
mainli
came
wuhan
qinghai
provinc
locat
qinghaitibet
plateau
averag
altitud
meter
sea
level
popul
million
report
total
confirm
case
april
outbreak
qinghai
rapidli
institut
number
strict
control
measur
lower
transmiss
includ
enforc
quarantin
measur
earli
detect
reduc
passeng
flow
strong
social
messag
april
new
confirm
case
found
qinghai
provinc
consecut
day
sinc
feb
importantli
patient
includ
sever
ill
case
discharg
treatment
feb
figur
studi
report
epidemiolog
clinic
characterist
outcom
confirm
patient
qinghai
includ
famili
cluster
return
qinghai
wuhan
famili
member
travel
wuhan
retrospect
studi
enrol
patient
infect
hospit
design
treatment
health
commiss
qinghai
provinc
jan
april
patient
fourth
peopl
hospit
qinghai
provinc
patient
third
peopl
hospit
xine
confirm
patient
enrol
studi
diagnos
accord
world
health
organ
interim
guidanc
confirm
case
defin
posit
result
realtim
reversetranscriptas
polymeras
chain
reaction
rtpcr
assay
nasal
pharyng
swab
specimen
incub
period
defin
contact
symptomat
case
ill
onset
studi
approv
ethic
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
commiss
two
hospit
requir
inform
patient
consent
waiv
ethic
committe
retrospect
studi
epidemiolog
demograph
clinic
laboratori
radiolog
characterist
treatment
outcom
data
obtain
patient
medic
record
inform
record
includ
demograph
data
exposur
histori
comorbid
symptom
laboratori
find
comput
tomograph
ct
scan
laboratori
confirm
realtim
pcr
done
mild
case
clinic
symptom
mild
without
pneumonia
manifest
imag
result
moder
case
fever
respiratori
symptom
pneumonia
manifest
imag
result
sever
case
meet
one
follow
respiratori
distress
rr
rest
xine
adjust
accord
altitud
need
correct
accord
altitud
mention
treatment
measur
collect
hospit
antivir
therapi
antibacteri
therapi
corticosteroid
therapi
tradit
chines
medicin
therapi
immun
support
therapi
convalesc
plasma
therapi
respiratori
support
discharg
criteria
base
guidelin
version
nhcc
follow
bodi
temperatur
normal
day
respiratori
symptom
pulmonari
imag
improv
significantli
respiratori
tract
specimen
nucleic
acid
amplif
test
neg
two
consecut
occas
least
hour
apart
categor
variabl
describ
frequenc
rate
percentag
continu
variabl
describ
use
median
interquartil
rang
iqr
valu
statist
analys
done
use
graphpad
prism
softwar
version
unless
otherwis
indic
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
patient
identifi
confirm
case
includ
studi
januari
februari
figur
among
patient
categor
sever
moder
mild
group
respect
hospit
sever
patient
initi
classifi
moder
chang
sever
diseas
progress
total
patient
return
wuhan
hubei
provinc
china
remain
case
patient
contact
confirm
case
patient
contact
famili
member
return
wuhan
neg
result
nucleic
acid
amplif
test
total
cluster
infect
identifi
involv
case
median
age
year
rang
year
men
five
patient
includ
sever
patient
chronic
diseas
includ
hypertens
hyperlipidemia
diabet
liver
injuri
polymyos
tabl
admiss
common
symptom
cough
sputum
product
chest
tight
fever
fatigu
sever
patient
show
cough
sputum
product
chest
tight
show
fever
tabl
less
common
symptom
sore
throat
diarrhoea
tabl
three
secondgener
case
credibl
inform
contact
incub
period
day
median
time
departur
wuhan
admiss
day
iqr
chest
xray
ct
examin
perform
patient
admiss
patient
patient
show
bilater
pneumonia
patient
show
unilater
pneumonia
patient
show
abnorm
tabl
common
abnorm
groundglass
opac
patchi
shadow
figur
admiss
patient
leucopenia
lymphopenia
neutropenia
eosinophilia
respect
tabl
hemoglobin
normal
rang
patient
may
attribut
high
altitud
alanin
aminotransferas
alt
aspart
aminotransferas
ast
concentr
elev
patient
includ
sever
patient
tabl
elev
level
lactat
dehydrogenas
ldh
creatin
kinas
found
case
respect
one
patient
polymyos
show
abnorm
creatin
kinas
ul
ldh
ul
alt
ul
ast
ul
elev
glucos
lactic
acid
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
found
similarli
patient
demonstr
elev
creactiv
protein
level
erythrocyt
sediment
rate
respect
notabl
level
creactiv
protein
sever
patient
higher
mild
moder
patient
tabl
tabl
treatment
condit
patient
improv
significantli
ct
imag
show
obviou
regress
ground
glass
opac
figur
patient
includ
sever
case
discharg
median
time
convers
nucleic
acid
amplif
test
posit
neg
day
iqr
median
length
hospit
stay
day
iqr
first
laboratoryconfirm
case
qinghai
report
januari
provinc
leadership
initi
firstlevel
respons
day
total
case
import
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
due
earli
detect
earli
diagnosi
strategi
patient
confirm
earli
stage
wuhan
asymptomat
patient
qinghai
cohort
diagnos
nucleic
acid
amplif
test
normal
chest
ct
examin
worth
note
one
secondgener
patient
contact
presum
contract
son
return
wuhan
symptom
therefor
identifi
contain
asymptomat
case
import
measur
prevent
transmiss
observ
greater
number
men
women
among
case
infect
consist
previou
studi
addit
children
infect
show
mild
moder
symptom
sever
case
comorbid
hypertens
liver
diseas
diabet
infect
host
cell
angiotensinconvert
enzym
receptor
highli
express
heart
lung
involv
heart
function
develop
hypertens
diabet
liver
injuri
patient
infect
might
also
directli
caus
viral
infect
liver
cell
elev
alt
ast
observ
patient
includ
sever
case
case
polymyos
admiss
therefor
liver
damag
preval
sever
case
mild
moder
case
consist
previou
report
elev
amount
creactiv
protein
may
associ
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
inflammatori
respons
cytokin
storm
caus
viru
blood
vessel
previou
studi
show
creactiv
protein
level
posit
correl
sever
pneumonia
similarli
found
amount
creactiv
protein
higher
sever
patient
mild
moder
patient
qinghai
locat
elev
plateau
lower
ambient
oxygen
level
compar
live
lower
altitud
patient
high
altitud
less
toler
hypoxia
lung
diseas
like
caus
respiratori
failur
therefor
oxygen
suppli
import
patient
especi
sever
patient
sever
patient
acut
respiratori
distress
syndrom
ard
low
prompt
noninvas
mechan
ventil
addit
antivir
antibiot
therapi
tradit
chines
medicin
sever
case
receiv
immunoglobulin
methylprednisolon
short
durat
convalesc
plasma
use
improv
surviv
rate
patient
sever
acut
respiratori
syndrom
sar
coronaviru
infect
use
convalesc
plasma
treatment
middl
east
respiratori
syndrom
mer
coronaviru
establish
protocol
thu
sever
patient
given
convalesc
plasma
qod
twice
collect
patient
recov
detect
antibodi
igg
igm
convalesc
plasma
one
donat
patient
use
chemiluminesc
immunoassay
level
igg
high
auml
igg
auml
expect
level
igm
low
auml
ct
imag
blood
ga
analysi
symptom
improv
convalesc
plasma
transfus
advers
event
observ
one
possibl
explan
efficaci
convalesc
plasma
antibodi
convalesc
plasma
might
suppress
viraemia
studi
sever
limit
first
limit
number
case
qinghai
provinc
result
interpret
caution
second
investig
correl
viral
load
dynam
cellular
immun
respons
may
relat
sever
third
time
convalesc
plasma
transfus
antibodi
level
test
igg
igm
et
al
yet
routin
introduc
hospit
treatment
guidelin
use
convalesc
plasma
releas
measur
antibodi
concentr
sever
patient
convalesc
plasma
transfus
difficult
accur
evalu
efficaci
relat
convalesc
plasma
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
summari
patient
discharg
treatment
immunotherapi
includ
convalesc
plasma
could
benefici
sever
patient
strategi
earli
detect
earli
diagnosi
earli
isol
earli
treatment
qinghai
import
prevent
transmiss
improv
cure
rate
author
declar
compet
interest
studi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
